价格

the-124

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES
EP 3998070 B1申请人: ABIVAX优先权: 2014
CN
EP
US
12 件公开
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US 7812218 B2申请人: EVOGENE LTD优先权: 2004
CN
US
9 件公开
TRANSPOSASE MUTANT WITH ENHANCED EFFICIENCY OF GENE TRANSFER
EP 4353821 A1申请人: MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT优先权: 2022
CN
EP
US
WO
5 件公开
TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA
EP 4619016 A4申请人: INDAPTUS THERAPEUTICS INC优先权: 2022
CN
EP
US
WO
5 件公开
QUINOLINE DERIVATIVE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF
US 20260216180 A1申请人: JIANGSU CAREPHAR PHARMACEUTICAL CO LTD优先权: 2023
CN
EP
US
WO
5 件公开
Wnt7 variants capable of activating g-protein coupled receptor (Gpr)124/Reck/frizzled/lipoprotein receptor-related protein (LRP)-mediated Wnt signaling
US 11840557 B2申请人: UNIV BRUXELLES优先权: 2018
CN
EP
US
5 件公开
Methods of differentiating stem cells by modulating MIR-124
US 9457053 B2申请人: ACCELERATED BIOSCIENCES CORP优先权: 2012
CN
US
5 件公开
TACE NAVIGATION GUIDANCE BASED ON TUMOR VIABILITY AND VASCULAR GEOMETRY
EP 3203913 A1申请人: KONINKLIJKE PHILIPS NV优先权: 2014
CN
EP
US
WO
4 件公开
TRANSCRIPTIONAL AND TRANSLATIONAL DUAL REGULATED ONCOLYTIC HERPES SIMPLEX VIRUS VECTORS
- EP 4469587 A4
  申请人: VIROGIN BIOTECH CANADA LTD优先权: 2022
  CN
  EP
  US
  WO
  4 件公开
- EP 4313094 A4
  申请人: VIROGIN BIOTECH CANADA LTD优先权: 2021
  EP
  US
  WO
  3 件公开
MIR-124 INDUCER, AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4667460 A1申请人: NANJING SYNNOCARE PHARMACEUTICAL TECH CO LTD优先权: 2023
CN
EP
US
WO
4 件公开

药物

the-124

专利

TRANSCRIPTIONAL AND TRANSLATIONAL DUAL REGULATED ONCOLYTIC HERPES SIMPLEX VIRUS VECTORS